NCT02157467
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
Not specified
Clinical trial condition
Infection, Human Immunodeficiency Virus
Explore clinical trials studying Infection, Human Immunodeficiency Virus. Study availability and eligibility vary by location and protocol.
107 public trials
2 recruiting studies
Infection, Human Immunodeficiency Virus trial results
NCT02277600
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site San Antonio, Texas, United States
NCT00951015
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Bakersfield, California, United States
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site San Francisco, California, United States
NCT01449929
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Aurora, Colorado, United States
NCT02076178
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Boston, Massachusetts, United States
NCT00920426
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Fort Lauderdale, Florida, United States
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site Vero Beach, Florida, United States
- GSK Investigational Site Charlotte, North Carolina, United States
Completed
Drug-drug Interaction (DDI) Rifabutin
NCT02138084
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
NCT02480894
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site San Antonio, Texas, United States
NCT02467335
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Hamilton, New Jersey, United States
NCT00453440
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Woolwich, London, London, United Kingdom
- GSK Investigational Site Birmingham, Warwickshire, United Kingdom
- GSK Investigational Site Birmingham, United Kingdom
- GSK Investigational Site London, United Kingdom